Upload
nerys
View
81
Download
6
Embed Size (px)
DESCRIPTION
IMMUNOHISTOCHEMISTRY AND IMMUNOPATHOLOGY PRACTICE IN PULMONARY PATHOLOGY Dr. Kemal BAKIR Gaziantep University, Medical Faculty, Department of Pathology. PRESENTATION History Aim Methods IHC in Pulmonary Pathology Pitfalls in IHC Conclusion. HISTORY: - PowerPoint PPT Presentation
Citation preview
11TTS 10th Annual Congress April 25th-TTS 10th Annual Congress April 25th-
29th 2007 - ANTALYA29th 2007 - ANTALYA
IMMUNOHISTOCHEMISTRY AND IMMUNOPATHOLOGY PRACTICE IN PULMONARY
PATHOLOGY
Dr. Kemal BAKIR
Gaziantep University, Medical Faculty, Department of Pathology
22
PRESENTATION
History
Aim
Methods
IHC in Pulmonary Pathology
Pitfalls in IHC
Conclusion
33
HISTORY:
Diagnostic immunochemistry was first introduced in 1940s by Coons et al who defined bacterial antigens and fluorescein-binded antibodies in infected tissues.
Being used for the last 30 years, improvement of immunohistochemistry (IHC) occured at the end of 1980s and the beginning of 1990s.
Although a few antibodies were included in the panel at the beginning, thousands of antibodies are now used in routine practice.
44
Immunopathology:
•immunohistochemistry,
•immunofluorescein,
•in situ hybridisation.
55
Immunopathology can be applied to
•Tissue sections,
•Aspiration materials,
•Fluids such as bronchoalveolar lavage
66
77
Tissue antigen
Rabbit immünoglobulin GSheep anti-rabbit IgG
Label (fluorescein, ferritin, enzyme)
88
Direct method
99
Two-step indirect method
1010 Three-step indirect method
1111
Soluble Enzyme Immune Complex Technıques
1212
1313
1414
1515
1616
In situ hybridisation (ISH) is a system depending on a labelled riboprobe, that is complementary to a unique nucleic acid sequence (which is tried to be evaluated or to be shown) in target cell or organisms
Probes which are used in (ISH) may also be labelled with digoxigenin. The probe can be detected using enzyme-labeled anti-digoxigenin antibody.
This technique also allows precise localization and can be quantitatively assessed.
1717
History
Aim
Methods
IHC in Pulmonary Pathology
Pitfalls in IHC
Conclusion
1818
When IHC used?
• confirm the diagnosis with HE • contribute to etiopathogenesis • establish various cell types and areas of
accumulations in inflammatory processes • manage treatments and to investigate new
treatment modalities • evaluate prognostic parameters• get information about mechanisms of rejection and
damage in transplantations
1919
History
Aim
Methods
IHC in Pulmonary Pathology
Pitfalls in IHC
Conclusion
2020
There are many steps in IHC :
Routin Tissue Processing Practicing of IHC Interpretation of IHC
2121
Routin Tissue Processing
•Tissue fixation ( Type and duration of fixation) •Tissue processing•Deparaffinisation
2222
Practicing of IHC
•Antigen retrieval •Staining method and protocol•Validity of solutions used in the staining procedure •Controls
2323
Interpretation of IHC
•Working of the technician and pathologist in harmony •To choose the antibody panel•Sensitivity of the antibody panel •Clone of the antibody•Right interpretation, scoring and evaluation of the positivities.
2424
2525
2626
2727
Detection Systems:
PAP
APAAP
(Strept)avıdın-bıotın
Polymer-based Technology
Staınıng Of Multıple Tıssue Markers At The Same Tıme
2828
Although IHC is generally used with avidin-biotin based detection systems, polymer-based detection systems are now being used because of false results due to binding of biotin with cells especially in kidneys and liver.
2929
It’s supposed that tyramin-based amplification systems will be used more efficiently in the future
3030
Immunohistochemical reactivity is observed in cells and in stroma.
The reactivity in cells may be membranous, cytoplasmic and/or nuclear .
The reactivity is assesed considering either the staining extent or intensity (or a combination of both), and the results are evaluated in a wide spectrum, with ‘positive’ at one end, and ‘negative’ at the other (e.g. Weak, intermediate, strong reactivity; or +,++,+++…)
3131
membranöz
3232
Nükleer ve sitoplazmik
3333
History
Aim
Methods
IHC in Pulmonary Pathology
Pitfalls in IHC
Conclusion
3434
When pulmonary pathology is considered; IHC may be helpful in:
Diffuse parenchymal pulmonary disorders,
Diseases such as COPD and asthma,
To assess the number and types of inflammatory cells
Infective diseases
Benign and malignant pulmonary neoplasia
Mesothelial lesions
Experimental studies cocerning pathogenesis and treatment modalities.
3535
In Asthmatic Patients;
Chronic T-cell mediated immunologic reaction on the bronchial wall of asthmatic patients was investigated immunohistochemically.
T-cells (CD2, CD5, CD7 and CD8 monoclonal antibodies),
B cells ( CD19, CD20 monoclonal antibodies),
Monocytes and macrophages (CD 68),
Eosinophils (EG1) and
Activated eosinophils (EG2) were tried to be shown and assessed quantitatively.
3636
In addition, CD4:CD8 ratio was determined by a double staining immunopathology procedure to assess T-cell subtypes.
3737
The number and ratio of T-cells, eosinophils and macrophages can be established in biopsies from proximal airways and bronchioloalveolar lavage (BAL) from distal airways.
In sudden deaths due to asthma, T-cell lymphocytosis is increased in BAL.
This increase was not observed in asthmatic patients and it was relatively preserved as normal. CD4:CD8 ratio is reversed with an increase in CD8+ T-cells.
3838
Eosinophilia and immunohistochemical nitric oxide positivity in
sputum,
lavage and
BALspecimens
are helpful in differential diagnosis of eosinophilic bronchitis and asthma which have similar clinical presentations.
3939
CD8+ T-cells were investigated in patients with chronic obstructive pulmonary disease (COPD). When compared with non-smokers, an increase in CD8 was observed in smokers.
The role of smoking in pathogenesis of COPD was demonstrated by this way.
4040
Immunopathology, especially IHC also helps in the diagnosis and follow-up of diffuse parenchymal pulmonary diseases
4141
IHC is also used in experimental studies which investigate pulmonary pathologies in humans and try to develop new therapeutic approaches.
One of them is to determine the accumulating cell type and localisation in pulmonary hypersensitivity.
•Dendritic cells tend to accumulate arround bronchioles
•Macrophages prefer arteries
•CD4+ T cells tend to accumulate at the same locations with dendritic cells.
4242
Lung cancer is the first leading cause of death due to cancer worldwide.
Non-small cell lung carcinoma (NSCLC) accounts for more than 80% of all lung carcinomas.
For this reason, it’s essential to make the differential diagnosis of these tumors and predicting the prognosis.
4343
β-catenin is used in differential diagnosis of adenocarcinomas.
Positivity of c-kit is helpful in the differential diagnosis of adenocarcinomas, on the other hand it’s also related with prognosis.
4444Β-katenin
4545
IHC is also used to determine prognostic factors in NSCLC.
These molecular prognostic factors are classified as: 1. Growth factors and receptors, oncogenes2. Programmed cell death3. Regulation of cell cyclus4. Angiogenesis and tumor progression
4646
4747
4848RNP
4949
Another field of IHC is the differential diagnosis of mesothelioma from adenocarcinoma. For this purpose;
calretinin, cytokeratin5/6, podoplanin, WT1 and also
MOC-31, Ber-EP4, B72.3, CEA, BG-8 and TTF-1 may be used.
5050
.
MOC-31,
Ber-EP4,
estrogen receptors and
calretinin
are known to be useful markers in differantial diagnosis of peritoneal mesothelioma and serous carcinoma.
5151
MOC-31,
Ber-EP4,
CEA,
BG-8 and
p63
are all expressed in squamous cell carcinomas and may be used in differantial diagnosis of epitheloid mesothelioma and squamous cell carcinomas.
5252
Mesothelial markers D2-40 and podoplanin, which are being used recently, show positive staining in 90% of epithelioid mesotheliomas.
5353
D2-40 AC-Adeno D2-40 Mesotelioma
5454
Immuncytochemistry (ICC) is a procedure applied to effusion cytology samples and especially to
•Smears,
•Cytospin
•Thinprep preparations.
Since there are problems in application and interpretation of cytologic samples, cell blocks of these materials are preferred for ICC.
5555
5656
Most appropriate samples for ICC are provided by cell blocks.
Also in pulmonary pathology,
Cell blocks are prepared from - sputums,
- bronchial washings and - pleural fluids
so that sections showing cells together which are appropriate for ICC can be obtained.
5757
History
Purpose
Methods
IHC in Pulmonary Pathology
Pitfalls in IHC
Conclusion
5858
Technical pitfalls•Fixation•Tissue processing •Antigen retrieval•Detection systems
Professional pitfalls •Choice of panel•Sensitivity of panel•Selection of type of antibody•Selection clone of the antibody•Interpretation of the results•Interpretation of the literature
5959
Tissue Fixation:
Rapid fixation (drying of the tissue or solution without fixative)
Type of fixation (formalin, B-5, Bouin, glycol-based fixative)
Duration of fixation (a few hours for small tissues)
6060
Tissue processing:
Temperature of the paraffin
Thickness of the sections
6161
Detection Systems:
Avidin-biotin
Dekstran-polymer
6262
Antigen Retrieval:
Enzyme
Temperature
Tamponade
6363
Choosing a panel:
DiagnosisDiagnosis Panel usedPanel used Panel preferredPanel preferredCarcinomaCarcinoma PancytokeratinPancytokeratin PancytokeratinPancytokeratinLymphomaLymphoma CD45CD45 CD45 + CD43CD45 + CD43MelanomaMelanoma S-100S-100 S-100 and Melan AS-100 and Melan ASarcomaSarcoma VimentinVimentin Kollajen type IV and VimentinKollajen type IV and Vimentin
Algorhythm is important in choosing a panel.
6464
Selection of clone of antibody:
Each clone has different sensitivity
In studies using different types of clones, results of IHC staining showed marked variations.
6565
Variations in interpretation:
Technical findings and the literature should be evaluated together.
Shoud be evaluated together with the controls.
6666
History
Purpose
Methods
IHC in Pulmonary Pathology
Pitfalls in IHC
Conclusion
6767
HE for tissue samples
Light microscopic examination of Papanicolau, Giemsa and HE-stained preparations for cytopathology are still golden standarts
Ancillary methods such as IHC and ICC are obviously helpful in
confirming the diagnosis,
contribute to ethiopathogenesis,
selection of treatment modalities and follow up.
6868
6969
Working in harmony with the technician
Right fixative
Right IHC detection systems
Right panels of antibodies
are essential for these methods.
7070
7171
All of the basic principles used in diagnosis with HE should be performed to IHC practice.
This will lead to less diagnostic errors.
COOPERATION WITH CLINICIANS AND PLANNING STUDIES TOGETHER ESPECIALLY,
WILL BE INCREASED THE EFFECT OF IHC
7272
TEŞEKKÜRLER TEŞEKKÜRLER